Regenerative medicine: Targeted genome editing in vivo

Lixia Wang, Jun Wu, Weiwei Fang, Guang Hui Liu, Juan Carlos Izpisua Belmonte

Research output: Contribution to journalArticle

6 Scopus citations


The CRISPR/Cas system has proven to be a powerful gene editing tool both in vitro and in vivo. A recent flurry of studies of in vivo gene editing using the CRISPR/Cas system bring bright prospects in creating animal models and targeted gene therapy of human genetic diseases.

Original languageEnglish (US)
Pages (from-to)271-272
Number of pages2
JournalCell Research
Issue number3
StatePublished - Mar 5 2015


ASJC Scopus subject areas

  • Molecular Biology
  • Cell Biology

Cite this

Wang, L., Wu, J., Fang, W., Liu, G. H., & Belmonte, J. C. I. (2015). Regenerative medicine: Targeted genome editing in vivo. Cell Research, 25(3), 271-272.